Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women

Clinical trial NCT02377349 · COMPLETED

Trial details

NCT number: NCT02377349
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2015-10-14
Primary completion: 2017-08-14
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.